Matches in Wikidata for { <http://www.wikidata.org/entity/Q64237725> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q64237725 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64237725 description "scholarly article by Lutz Frölich et al published 12 February 2019 in Alzheimers Research & Therapy" @default.
- Q64237725 description "wetenschappelijk artikel" @default.
- Q64237725 description "наукова стаття, опублікована в лютому 2019" @default.
- Q64237725 name "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 name "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 type Item @default.
- Q64237725 label "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 label "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 prefLabel "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 prefLabel "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 P1433 Q64237725-E82774B1-E8BE-4684-8018-1BC8BB99D5C4 @default.
- Q64237725 P1476 Q64237725-EF3A0B98-1390-4F89-8A19-C282E9B091DC @default.
- Q64237725 P2093 Q64237725-0AAB86EC-8CC8-4D22-B555-D8F224702B94 @default.
- Q64237725 P2093 Q64237725-0EB2AE5A-2B0B-4468-8709-413E99E54BD8 @default.
- Q64237725 P2093 Q64237725-636B6B0B-C56C-4878-8579-40C9CCF62705 @default.
- Q64237725 P2093 Q64237725-8BD2E41D-0EA7-426D-9EAE-5B1F2CEC09ED @default.
- Q64237725 P2093 Q64237725-8D564AEB-6600-43F3-9D6A-345D85B6A556 @default.
- Q64237725 P2093 Q64237725-8DED52DA-2D2C-4351-94D1-420C12B6D968 @default.
- Q64237725 P275 Q64237725-a79169ff-71ee-44d7-ab78-5c2910f94054 @default.
- Q64237725 P2860 Q64237725-0382EC68-E385-43C4-A4D3-12FDE5F013AA @default.
- Q64237725 P2860 Q64237725-09CC852B-5743-48D7-B850-8B8C015EA2D7 @default.
- Q64237725 P2860 Q64237725-0A6C8EC4-B514-4C28-B400-D16CF07FA2DB @default.
- Q64237725 P2860 Q64237725-0A98334E-556F-4564-A8D8-A9B220203D2B @default.
- Q64237725 P2860 Q64237725-0C3EEF18-4D54-4E76-B24C-24CBDF329D40 @default.
- Q64237725 P2860 Q64237725-16EA4B77-AE5E-4EC5-BF93-331E899B255F @default.
- Q64237725 P2860 Q64237725-26CA775E-DC1C-49F9-A5DA-7BDB66BE3ED8 @default.
- Q64237725 P2860 Q64237725-3B182575-F161-4717-AF7B-C5493F135D78 @default.
- Q64237725 P2860 Q64237725-4F7B52AC-5E37-4CC8-8322-4E3DDCE58AEB @default.
- Q64237725 P2860 Q64237725-830FD9E7-B29A-4C97-9CB9-633BB617725E @default.
- Q64237725 P2860 Q64237725-847C52BA-50DC-43D4-99FA-5ADE5659A87F @default.
- Q64237725 P2860 Q64237725-8A937190-F2BB-4791-8712-E8D9BE8289F0 @default.
- Q64237725 P2860 Q64237725-A85CE108-4F6F-43D4-B706-DA858CC9EF07 @default.
- Q64237725 P2860 Q64237725-CC98207E-0F3E-4E11-A6EF-AD90CC834D94 @default.
- Q64237725 P2860 Q64237725-E483E91E-5642-4445-83F4-330E32B3634E @default.
- Q64237725 P2860 Q64237725-F3800903-E226-41DE-A85C-4068076B2ABE @default.
- Q64237725 P2888 Q64237725-FFA5D4CC-BFBD-43A5-843D-91EC5CB913A3 @default.
- Q64237725 P304 Q64237725-16EB989C-C6F6-499D-8559-88DD284943EF @default.
- Q64237725 P31 Q64237725-70025B30-1108-43DB-8462-22377A004D45 @default.
- Q64237725 P356 Q64237725-9B6DBA55-DBAE-46A9-9A6E-EA0F76F4FCE1 @default.
- Q64237725 P407 Q64237725-66B55282-82E1-4826-8E6C-AEC7F916EEA9 @default.
- Q64237725 P433 Q64237725-F79F4087-D652-4FDC-9E2F-5643285F0064 @default.
- Q64237725 P478 Q64237725-BA86B8BB-D673-4826-BD40-84EE799B4974 @default.
- Q64237725 P577 Q64237725-B96EFE3E-C455-45B3-900A-B4E5AD47A713 @default.
- Q64237725 P6179 Q64237725-0F191AF8-E03E-4614-8BF3-8DB63BAE5ABF @default.
- Q64237725 P6216 Q64237725-9066f896-da96-45c3-a325-9c6b11cc0ce0 @default.
- Q64237725 P698 Q64237725-73A89987-2041-4C5D-BB8A-BCA9587B65E0 @default.
- Q64237725 P921 Q64237725-32D42216-C25A-4FBD-B3A9-E7D53DDA37FB @default.
- Q64237725 P932 Q64237725-6B596640-C862-44B3-A3BC-A693C5149755 @default.
- Q64237725 P356 S13195-019-0467-2 @default.
- Q64237725 P698 30755255 @default.
- Q64237725 P1433 Q15716761 @default.
- Q64237725 P1476 "Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease" @default.
- Q64237725 P2093 "Bruno Dubois" @default.
- Q64237725 P2093 "Claus Thamer" @default.
- Q64237725 P2093 "Glen Wunderlich" @default.
- Q64237725 P2093 "Lutz Frölich" @default.
- Q64237725 P2093 "Michael Roehrle" @default.
- Q64237725 P2093 "Miguel Garcia" @default.
- Q64237725 P275 Q20007257 @default.
- Q64237725 P2860 Q28300546 @default.
- Q64237725 P2860 Q30458193 @default.
- Q64237725 P2860 Q33805090 @default.
- Q64237725 P2860 Q34635272 @default.
- Q64237725 P2860 Q35059553 @default.
- Q64237725 P2860 Q35163534 @default.
- Q64237725 P2860 Q37245947 @default.
- Q64237725 P2860 Q38643963 @default.
- Q64237725 P2860 Q38852543 @default.
- Q64237725 P2860 Q39444315 @default.
- Q64237725 P2860 Q41318515 @default.
- Q64237725 P2860 Q41444802 @default.
- Q64237725 P2860 Q48790299 @default.
- Q64237725 P2860 Q50532959 @default.
- Q64237725 P2860 Q51899592 @default.
- Q64237725 P2860 Q53313597 @default.
- Q64237725 P2888 s13195-019-0467-2 @default.
- Q64237725 P304 "18" @default.
- Q64237725 P31 Q13442814 @default.
- Q64237725 P356 "10.1186/S13195-019-0467-2" @default.
- Q64237725 P407 Q1860 @default.
- Q64237725 P433 "1" @default.
- Q64237725 P478 "11" @default.
- Q64237725 P577 "2019-02-12T00:00:00Z" @default.
- Q64237725 P6179 "1112092089" @default.
- Q64237725 P6216 Q50423863 @default.
- Q64237725 P698 "30755255" @default.
- Q64237725 P921 Q11081 @default.
- Q64237725 P932 "6371616" @default.